LumiraDx (LumiraDx) Total Liabilities : $555.55 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Total Liabilities?

LumiraDx's Total Liabilities for the quarter that ended in Jun. 2023 was $555.55 Mil.

LumiraDx's quarterly Total Liabilities declined from Dec. 2022 ($546.39 Mil) to Mar. 2023 ($545.91 Mil) but then increased from Mar. 2023 ($545.91 Mil) to Jun. 2023 ($555.55 Mil).

LumiraDx's annual Total Liabilities declined from Dec. 2020 ($890.31 Mil) to Dec. 2021 ($482.18 Mil) but then increased from Dec. 2021 ($482.18 Mil) to Dec. 2022 ($546.39 Mil).

LumiraDx Total Liabilities Historical Data

The historical data trend for LumiraDx's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Total Liabilities Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Total Liabilities

890.31

482.18

546.39

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Liabilities	Get a 7-Day Free Trial								558.84	550.90	546.39	545.91	555.55

LumiraDx Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LumiraDx's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	91.798	+	(388.782	+	49.497
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	16.311	+	0)
	=	546.39

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	441.013	-	-105.375
	=	546.39

LumiraDx's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	390.447	+	(92.466	+	57.935
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	14.706	+	0)
	=	555.55

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	341.607	-	-213.947
	=	555.55

LumiraDx Total Liabilities Related Terms

Thank you for viewing the detailed overview of LumiraDx's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

LMDXF:USA

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.